| Financial Year |
March 31 2023 |
| Monetary Funds |
1,279,232,831.96 |
| Held-for-trading Financial Assets |
38,279,100.30 |
| Notes Receivable |
127,696,696.82 |
| Accounts Receivable |
1,125,928,255.88 |
| Advances to Suppliers |
30,154,601.83 |
| Other Receivables |
52,020,950.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,261,630.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,894,103.51 |
| Total Current Assets |
2,963,739,513.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,764,154.47 |
| Investment Properties |
55,948,812.24 |
| Fixed Assetes |
1,369,935,841.96 |
| Under-construction Projects |
215,380,144.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,517,244.37 |
| R&D expenses |
2,195,075.48 |
| Goodwill |
249,803,714.05 |
| Long-Term Deferred and Prepaid Expenses |
63,052,231.39 |
| Deferred Income Tax Assets |
94,899,345.95 |
| Other Non-Current Assets |
65,112,604.56 |
| Sub-Total of Non-Current Assets |
2,600,014,012.67 |
| Total Assets |
5,563,753,525.78 |
| Short-Term Loans |
627,493,694.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
76,326,857.86 |
| Accounts Payable |
255,637,421.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,585,921.69 |
| Taxes Payable |
11,501,704.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,342,195.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
123,103,637.65 |
| Other Current Liabilities |
46,231,786.80 |
| Sub-Total of Current Liabilities |
1,445,596,922.98 |
| Long-term Loans |
252,400,083.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,036,975.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,917,187.76 |
| Deferred Income Tax Liabilities |
22,570,522.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
566,876,395.94 |
| Total Liabilities |
2,012,473,318.92 |
| Paid-In Capital(Or Share Stock) |
575,225,846.00 |
| Capital Surplus |
1,981,738,340.49 |
| Surplus Reserve |
76,892,277.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
850,015,488.77 |
| Minority Stockholder's Interest |
67,965,174.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,483,315,032.78 |
| Owner's Equity（Stockholder's Equity） |
3,551,280,206.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,563,753,525.78 |
